2.1 Pulse Oximetry, Pre/Postductal & Transcutaneous Monitoring
Key Takeaways
- Pre-ductal pulse oximetry must be placed on the right hand or wrist, reflecting arterial blood delivered upstream of the ductus arteriosus via the innominate artery.
- A preductal-to-postductal saturation difference greater than about 5%–10% supports differential ductal shunting but does not by itself establish the cause; correlate with examination, blood pressure, gases, and echocardiography.
- Transcutaneous sensors heat skin to arterialize local capillary flow. Use the device-, gestation-, and skin-specific temperature and rotation interval, verify against blood gases, and inspect fragile skin frequently.
2.1 Pulse Oximetry, Pre/Postductal & Transcutaneous Monitoring
Noninvasive gas exchange monitoring represents a primary competency in neonatal and pediatric respiratory care. Continuous evaluation of oxygenation and carbon dioxide dynamics guides clinical decision-making, ventilator adjustments, and acute resuscitation while minimizing patient handling, painful invasive procedures, and iatrogenic blood loss.
Pulse Oximetry Principles & Spectrophotometric Physics
Pulse oximetry (SpO2) utilizes spectrophotometry combined with optical photoplethysmography to noninvasively measure functional arterial hemoglobin oxygen saturation. The sensor houses two low-voltage light-emitting diodes (LEDs) and a photodetector photodiode:
- Red Light (660 nm wavelength): Deoxygenated hemoglobin (RHb) absorbs significantly more light at 660 nm than oxygenated hemoglobin (HbO2).
- Infrared Light (940 nm wavelength): Oxygenated hemoglobin (HbO2) absorbs substantially more light at 940 nm than deoxygenated hemoglobin.
The photodetector measures light transmitted through the pulsatile vascular bed. The microprocessor isolates the pulsatile signal (AC component, representing expanding arterial blood volume during systole) from the non-pulsatile background (DC component, representing venous blood, capillary blood, bone, and soft tissue). The ratio of red-to-infrared absorbance ratios (R = [AC660/DC660] / [AC940/DC940]) is correlated against empirical calibration curves to display SpO2.
Clinical Limitations & Dyshemoglobins
- Carboxyhemoglobin (COHb): Standard two-wavelength pulse oximetry cannot distinguish COHb from oxyhemoglobin and may substantially overestimate useful oxygen saturation in carbon-monoxide exposure. Use co-oximetry when dyshemoglobinemia is suspected.
- Methemoglobin (MetHb): Increasing MetHb tends to drive a conventional two-wavelength reading toward approximately 85%, regardless of whether true saturation is higher or lower. Confirm with co-oximetry.
- Hypoperfusion and Shock: Hypothermia, vasoconstriction, shock, and vasoactive drugs can weaken the pulsatile signal. Judge the waveform or signal-quality indicator; a universal perfusion-index cutoff does not apply to every monitor.
- Motion and optical artifact: Motion, ambient light, venous pulsation, nail products, skin pigmentation, probe malposition, and device limitations can bias or destabilize the value. Correlate the number with the waveform and the patient.
Pre-Ductal vs. Post-Ductal SpO2 Monitoring
In transitional neonatal physiology and congenital cardiovascular pathology, comparing simultaneous pre-ductal and post-ductal saturations is vital for assessing intracardiac and extracardiac right-to-left shunting.
[Ascending Aorta]
│
┌───────────┴───────────┐
│ │
[Innominate Artery] [Left Carotid & Subclavian]
│ │
Right Subclavian ▼
│ [Aortic Isthmus]
Right Arm/Wrist │
(PRE-DUCTAL) ├──◄ [Ductus Arteriosus]
│ (Pulmonary Trunk Shunt)
▼
[Descending Aorta]
│
Lower Extremities
(POST-DUCTAL)
Vascular Anatomy & Probe Placement
- Pre-Ductal Site: The right hand or right wrist. Blood flows from the left ventricle into the ascending aorta and branches first into the innominate (brachiocephalic) artery, which gives rise to the right subclavian and right common carotid arteries. This blood perfuses the right upper extremity prior to the insertion of the ductus arteriosus.
- Post-Ductal Site: Use either foot. Lower-extremity blood reaches the descending aorta beyond the ductal insertion. The left hand is supplied from the aortic arch and is not a dependable postductal screening site because its relationship to ductal insertion varies.
Diagnostic Thresholds & Clinical Significance
A reproducible preductal saturation higher than the postductal saturation supports differential cyanosis and can reflect right-to-left ductal shunting, as in PPHN. The size of the difference varies with physiology and measurement quality; it is a clue rather than stand-alone confirmation. Reverse differential cyanosis—right hand lower than a foot—has a narrower congenital-cardiac differential. Correlate either pattern with simultaneous reliable signals, examination, blood gases, and echocardiography.
| Clinical Finding | Pre-Ductal SpO2 | Post-Ductal SpO2 | Pathophysiological Etiology |
|---|---|---|---|
| PPHN with right-to-left ductal flow | Often higher | Often lower | Deoxygenated pulmonary-artery blood enters the descending aorta through the PDA. Absence of a gradient does not exclude PPHN when shunting is mainly atrial or lung disease dominates. |
| Critical left-sided obstruction | May be higher | May be lower | Lower-body perfusion may depend on right-to-left ductal flow; weak femoral pulses, acidosis, and shock are crucial clues. |
| TGA with PPHN or arch obstruction | May be lower | May be higher | Reverse differential cyanosis can occur when relatively oxygenated pulmonary-artery blood enters the descending aorta through the PDA. |
Critical Congenital Heart Disease (CCHD) Screening Protocol
Follow the current jurisdictional and facility CCHD algorithm, generally at 24 hours of life or as late as possible before earlier discharge, using the right hand and one foot. Under the current U.S. CDC/AAP-aligned algorithm:
- Pass: SpO2 is ≥95% in both the right hand and foot and the absolute difference is ≤3%.
- Immediate fail: Any measurement is <90%.
- Repeat once in 1 hour: Either site is 90%–94%, or the difference is >3%. A second measurement with either site <95% or a difference >3% is a failed screen.
A failed screen requires prompt evaluation for cardiac and noncardiac causes of hypoxemia; echocardiography is commonly part of that evaluation. A pass does not exclude every critical congenital heart defect.
Transcutaneous Gas Monitoring (tcPO2 & tcPCO2)
Transcutaneous monitoring provides continuous, noninvasive estimates of arterial oxygen and carbon dioxide tension by measuring the diffusion of gases through the skin to heated electrochemical sensors.
[ Heated Sensor (42°C–44°C) ]
───────────────────────────────── ◄ Contact Gel Layer
Stratum Corneum (Lipids melt)
─────────────────────────────────
Epidermis (Avascular)
─────────────────────────────────
Dermal Capillary Bed (Hyperemia) ◄ Dissolved O2 / CO2 Diffuses Upward
Operating Mechanisms & Thermodynamics
- tcPO2 (Modified Clark Polarographic Electrode): Platinum cathode and silver anode immersed in an electrolyte solution. Applying a polarizing voltage of -600 to -800 mV reduces oxygen molecules, generating a current directly proportional to the number of reduced oxygen molecules.
- tcPCO2 (Modified Severinghaus pH Electrode): Glass pH-sensitive electrode and reference silver/silver-chloride electrode separated from skin by a Teflon membrane and bicarbonate electrolyte solution. Diffusing CO2 hydrates to carbonic acid (H2CO3), dissociating into H+ and HCO3-, altering pH in proportion to PCO2.
- Thermodynamic Hyperemization: The sensor heating element heats underlying cutaneous tissue to 42.0°C to 44.0°C. Heating liquefies the lipid bilayer of the stratum corneum, dilates dermal capillaries, increases local capillary blood flow (hyperemia) up to 7-fold, and shifts the oxyhemoglobin dissociation curve to the right, facilitating gas diffusion toward the skin surface.
Clinical Protocols & Temperature Selection
- Temperature and dwell time: Select both from the monitor manufacturer's instructions and unit protocol, reducing temperature or dwell time for fragile or poorly perfused skin. Common neonatal settings are around 42°C–44°C, but they are not universal. Inspect after placement and at every rotation; erythema or skin injury requires immediate reassessment.
- Calibration and membrane care: Follow the device schedule and recalibrate after indicated events such as membrane replacement or a failed calibration check. A fixed four-hour rule does not fit every monitor.
- Interpretation: Heating increases local perfusion and changes gas tension, so monitor algorithms compensate for temperature and local metabolic CO2. Compare trends with an appropriate blood sample at initiation, after major clinical change, and whenever the value conflicts with the examination. Shock, edema, hypothermia, vasoactive drugs, thick skin, poor contact, and membrane problems can degrade agreement.
A 38-week gestation neonate delivered via emergent cesarean section for fetal distress presents with severe respiratory failure and cyanosis. A pre-ductal pulse oximeter placed on the right wrist displays an SpO2 of 94%, while a post-ductal pulse oximeter placed on the left foot displays an SpO2 of 81% while receiving an FiO2 of 1.0. Which of the following conditions is most consistent with this clinical presentation?
A 26-week gestational age preterm infant weighing 750 grams is monitored in the neonatal intensive care unit with a combination transcutaneous oxygen and carbon dioxide monitor (tcPO2/tcPCO2). The unit protocol specifies 42°C–43°C with site rotation every 2 hours. Which procedure best follows that protocol to prevent iatrogenic skin injury and maintain accurate measurements?